GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IVim Technology 460470.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

2,155

-6.71%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About IVim Technology

Its shares trade on KOSDAQ under the ticker 460470.KQ. It has been listed since 6 August 2024. In the fiscal year to 31 December 2025, it reported revenue of ₩4.38bn and a net loss of ₩3.80bn. At that date it held total assets of ₩30.23bn and shareholders' equity of ₩27.64bn.

IVim Technology Inc is a KR-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2024-08-06. IVim Technology Inc is a Korea-based company principally engaged in the development, manufacture and sale of biological microscopes. The firm is principally engaged in the development, manufacture and sale of biological microscopes that can analyze complex dynamic changes in numerous cells in vivo based on in vivo live cell imaging platform technology. The firm is also engaged in the manufacture and sale of imaging accessories. In addition, the Company is engaged in the provision of cellular-level imaging acquisition inside the living body and kinetic analysis services of injected drugs.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
6 Aug 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • IVim Technology Inc develops biological microscopes for in vivo cell analysis in Korea.
  • The company manufactures imaging accessories for cellular-level imaging services.
  • IVim Technology Inc provides kinetic analysis services for injected drugs in Korea.

Weaknesses

  • IVim Technology Inc is a new company with IPO on 6 August 2024.
  • The company's business is limited to biological microscopes and imaging accessories.
  • IVim Technology Inc operates only in Daejeon, South Korea.

Opportunities

  • IVim Technology Inc can expand its biological microscope sales in the Health Care sector.
  • The company can grow its imaging accessory market in the Health Care Equipment & Supplies industry.
  • IVim Technology Inc may increase its kinetic analysis services for drug development.

Threats

  • IVim Technology Inc faces competition from established Health Care Equipment companies.
  • The company's new IPO may lead to market volatility for investors.
  • IVim Technology Inc's reliance on Daejeon for operations could limit growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.